Glucosamine Intensive Care, backed by rigorous research, offers significant advantages for patients dealing with mild osteoarthritis.

Joint Space Preservation: Clinical trials have consistently demonstrated that 1,500mg of glucosamine sulfate helps manage mild osteoarthritis.
Unlike the placebo group, patients taking glucosamine did not experience progressive joint space narrowing due to cartilage damage.
This preservation of joint space is crucial for maintaining joint health and mobility.

Pain Relief and Functionality: A comprehensive meta-analysis of 20 randomised clinical trials found that daily intake of 1,500mg glucosamine was superior to placebo in terms of pain reduction and functional improvement. Patients reported less discomfort and improved functionality, enhancing their quality of life.

Mechanism of Action and Tissue Support: Glucosamine plays a vital role in joint tissue composition. It contributes to the production of proteoglycans, mucopolysaccharides, and hyaluronic acid, essential components for healthy joints. Additionally, animal studies have shown that glucosamine inhibits IL-1?, reducing inflammation and swelling.

Glucosamine Intensive Care not only supports joint health but also enhances mobility. Its collagen-protective properties make it an excellent choice for patients seeking relief from osteoarthritis symptoms.

Warnings

Recommended daily dose contains 144mg of sodium.

Mineral supplements should not replace a balanced diet.

Not to be taken by children under two years old.

If symptoms persist consult your healthcare professional.